[[(1S,3R)-1-acetyloxy-1-[4-[[(2R)-1-(4-hydroxyphenyl)-4-methylpentan-2-yl]carbamoyl]-1,3-thiazol-2-yl]-4-methylpentan-3-yl]-[(2S)-3-methyl-2-[2-[(2R)-1-methylpiperidin-2-yl]-2-oxoethyl]pentanoyl]amino]methyl butanoate
C43H66N4O8S — CID 159326501
Data last refreshed: (MolForge compound catalog, from PubChem)
About [[(1S,3R)-1-acetyloxy-1-[4-[[(2R)-1-(4-hydroxyphenyl)-4-methylpentan-2-yl]carbamoyl]-1,3-thiazol-2-yl]-4-methylpentan-3-yl]-[(2S)-3-methyl-2-[2-[(2R)-1-methylpiperidin-2-yl]-2-oxoethyl]pentanoyl]amino]methyl butanoate
[[(1S,3R)-1-acetyloxy-1-[4-[[(2R)-1-(4-hydroxyphenyl)-4-methylpentan-2-yl]carbamoyl]-1,3-thiazol-2-yl]-4-methylpentan-3-yl]-[(2S)-3-methyl-2-[2-[(2R)-1-methylpiperidin-2-yl]-2-oxoethyl]pentanoyl]amino]methyl butanoate (PubChem CID 159326501) has the molecular formula C43H66N4O8S and a molecular weight of 799.09 g/mol. Its IUPAC name is [[(1S,3R)-1-acetyloxy-1-[4-[[(2R)-1-(4-hydroxyphenyl)-4-methylpentan-2-yl]carbamoyl]-1,3-thiazol-2-yl]-4-methylpentan-3-yl]-[(2S)-3-methyl-2-[2-[(2R)-1-methylpiperidin-2-yl]-2-oxoethyl]pentanoyl]amino]methyl butanoate.
Molecular Properties
| Compound Name | [[(1S,3R)-1-acetyloxy-1-[4-[[(2R)-1-(4-hydroxyphenyl)-4-methylpentan-2-yl]carbamoyl]-1,3-thiazol-2-yl]-4-methylpentan-3-yl]-[(2S)-3-methyl-2-[2-[(2R)-1-methylpiperidin-2-yl]-2-oxoethyl]pentanoyl]amino]methyl butanoate |
|---|---|
| PubChem CID | 159326501 |
| Molecular Formula | C43H66N4O8S |
| Molecular Weight | 799.09 g/mol |
| Exact Mass | 798.46 |
| IUPAC Name | [[(1S,3R)-1-acetyloxy-1-[4-[[(2R)-1-(4-hydroxyphenyl)-4-methylpentan-2-yl]carbamoyl]-1,3-thiazol-2-yl]-4-methylpentan-3-yl]-[(2S)-3-methyl-2-[2-[(2R)-1-methylpiperidin-2-yl]-2-oxoethyl]pentanoyl]amino]methyl butanoate |
| SMILES | CCCC(=O)OCN(C(=O)[C@@H](CC(=O)[C@H]1CCCCN1C)C(C)CC)[C@H](C[C@H](OC(C)=O)c1nc(C(=O)N[C@@H](Cc2ccc(O)cc2)CC(C)C)cs1)C(C)C |
| InChI | InChI=1S/C43H66N4O8S/c1-10-14-40(51)54-26-47(43(53)34(29(7)11-2)23-38(50)36-15-12-13-20-46(36)9)37(28(5)6)24-39(55-30(8)48)42-45-35(25-56-42)41(52)44-32(21-27(3)4)22-31-16-18-33(49)19-17-31/h16-19,25,27-29,32,34,36-37,39,49H,10-15,20-24,26H2,1-9H3,(H,44,52)/t29?,32-,34+,36-,37-,39+/m1/s1 |
| InChIKey | HQGWYVGFWJBJAM-NGWPIEKASA-N |
| XLogP | 7.49 |
| TPSA | 155.44 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 56 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 799.09 |
| LogP ≤ 5 | 7.49 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 11 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159326501 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.